FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs.When completed, the site will be the largest end-to-end cell culture CDMO facility in North America, housing state-of-the-art biopharmaceutical manufacturing equipment and technology, including two large manufacturing suites for large-scale monoclonal antibody drug substance and drug product manufacturing.
Fujifilm to Invest Additional $1 2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
RALEIGH — FUJIFILM Diosynth Biotechnologies North Carolina, Inc. will expand its biopharmaceutical manufacturing facility in Wake County, adding 680 jobs and investing $1.2 billion in the Town of Holly Springs,
FUJIFILM Diosynth Biotechnologies, a division of Japanese parent company Fujifilm Corp, plans to expand its job force at its Holly Springs location with an additional 680 jobs and a $1.2 billion investment as part of a $15 million Job Development Investment Grant (JDIG) awarded by the North Carolina Department of Commerce’s Economic Investment Committee (NCEIC).